Ciclopirox

This page contains recent news articles, when available, and an overview of Ciclopirox but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Diagnosis of Trichophyton rubrum from Onychomycotic Nail Samples ...  -  May 16, 2008
10 Although the most commonly used topical antifungal drugs are ciclopirox and amorolfine nail lacquers, the best mycologic and clinical cure rates can be Journal of the American Podiatric Medical Association (subscription)

Medicis Announces First Quarter 2008 Conference Call and Webcast  -  May 6, 2008
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline FOXBusiness

Ipsen and Medicis Announce Acceptance of Reloxin(R) BLA in ...  -  May 18, 2008
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline PR-Inside.com (Pressemitteilung),

Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development  -  May 6, 2008
2%; Oilatum(R) Cleansing Bar; Physiogel(R) Cream; Stieprox(R) (ciclopirox olamine) Shampoo; REVALESKIN(TM) Skin Care Products; and Sarna(R) Lotion. Trading Markets (press release),

International Diabetes Federation Grant Supports Diabetes Self ...  -  May 7, 2008
2%; Oilatum(R) Cleansing Bar; Physiogel(R) Cream; Stieprox(R) (ciclopirox olamine) Shampoo; REVALESKIN(TM) Skin Care Products; and Sarna(R) Lotion. Trading Markets (press release),

Medicis Announces the Early Adoption of Online Proxy Materials for ...  -  Apr 8, 2008
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline Primenewswire (press release),

Stiefel Laboratories Appoints First Chief Scientific Officer  -  Apr 7, 2008
Extina(R) (ketoconazole) Foam, 2%; Oilatum(R) Cleansing Bar; Physiogel(R); Stieprox(R) (ciclopirox olamine); REVALESKIN(TM); and Sarna(R). 新�美通(新闻�布),

Combination Terbinafine/Ciclopirox Effective for Toenail ...  -  Feb 11, 2008
They treated 414 subjects with daily ciclopirox nail lacquer for 48 weeks and three 2-week pulses of terbinafine 250 mg from weeks 12 to 24. DG News

DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan ...  -  Mar 6, 2008
...(benzoyl peroxide, 4% or 8%) packaged in the convenient new Brevoxyl Acne Wash Kit; Oilatum®; Physiogel®; Stieprox® (ciclopirox olamine); and Sarna®. CNNMoney.com

Businessnetwire.us: NASDAQ Stock News You Can Use: SMOD, DUSA, DAIO  -  Mar 6, 2008
Physiogel ; Stieprox (ciclopirox olamine); and Sarna . Its wholly-owned global network is comprised of more than 30 subsidiaries, manufacturing plants Trading Markets (press release),

Medicis Announces 2007 Fourth Quarter and Year-End Conference Call ...  -  Feb 26, 2008
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), FOXBusiness

Medicis Reports Fourth Quarter and Year End 2007 Financial Results  -  Feb 28, 2008
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline FOXBusiness

Nail Fungus - Treatments and Cure for Nail Fungus  -  Mar 2, 2008
The Food and Drug Administration has approved a topical antifungal lacquer called ciclopirox (Penlac), which you paint onto your infected nails and American Chronicle,

Stiefel Laboratories, Inc. Appoints New President  -  Feb 29, 2008
Physiogel(R); Stieprox(R) (ciclopirox olamine); REVALESKIN(TM); and Sarna(R). Its wholly-owned global network is comprised of more than 30 subsidiaries, Biloxi Sun Herald,

Medicis to Present At Merrill Lynch Conference  -  Feb 5, 2008
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline FOXBusiness

Arpida Reports Progress in Pivotal Phase III Trial With TLT ...  -  Jan 22, 2008
The comparator is 8% ciclopirox lacquer (Penlac(R)) applied daily to nails that have not undergone a prior laser pre-treatment. The treatment duration will Trading Markets (press release),

Perrigo gains from competitor's problems  -  Nov 1, 2007
On September 19, the Company announced it had received final approval from the FDA for ciclopirox topical solution, 8% (equivalent to Penlac Nail Lacquer), Globes,

Medicis to Present At 2007 Credit Suisse Annual Healthcare Conference  -  Nov 12, 2007
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline hcl), LOPROX(R) (ciclopirox), PLEXION(R) (sodium sulfacetamide/sulfur), SOLODYN(R) (minocycline CNNMoney.com

Stiefel Laboratories, Inc. Enters into Strategic Collaboration ...  -  Nov 6, 2007
Physiogel(R); Stieprox(R) (ciclopirox olamine); REVALESKIN(TM); and Sarna(R). Its wholly-owned global network is comprised of more than 30 subsidiaries, CNNMoney.com

BTRX: Positive Ph iia Data on Friday Lifts Stock from 52-Week Low ...  -  Oct 19, 2007
Penlac(R)(ciclopirox) 8% solution remains the sole prescription topical antifungal therapy effective for nail fungus. It is marketed by sanofi-adventis' Trading Markets (press release),

Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution  -  Sep 19, 2007
...that it has received final approval from the US Food and Drug Administration to manufacture and market Ciclopirox Topical Solution, 8% (Nail Lacquer). CNNMoney.com

Taro Receives FDA Approvals for Ciclopirox and Formulation of ...  -  Sep 24, 2007
The FDA approved Taro Pharmaceutical’s abbreviated new drug application (ANDA) for ciclopirox topical solution, 8 percent, for nail fungus infections and FDA news (subscription),

Taro Pharma Industries Gets FDA Approval For Its "ANDA" Of ...  -  Sep 20, 2007
PK) announced that it has received approvals from the US Food and Drug Administration for its Abbreviated New Drug Application or "ANDA" for Ciclopirox Trading Markets,

Synerx Pharma Announces Approval for Ciclopirox Topical 8% Solution  -  Sep 19, 2007
Synerx’s product is a generic equivalent of Dermik Laboratories’ prescription product Penlac®, a topical ciclopirox treatment for nail fungus. Business Wire (press release),

Hi-Tech Pharmacal Receives Approval for Ciclopirox Topical Solution  -  Sep 19, 2007
Hi-Tech's Ciclopirox topical solution is the generic equivalent of Dermik Laboratories' nail fungus treatment Penlac(R) topical solution, 8%, PharmaLive.com (press release),

FDA Approves Perrigo's Ciclopirox Topical Solution - Update [PRGO]  -  Sep 19, 2007
...said Wednesday the US Food and Drug Administration approved the manufacture and marketing of its Ciclopirox Topical Solution, 8% Nail Lacquer. RTT News,

Michigan business briefs  -  Sep 21, 2007
Perrigo Co. said it received final approval from the US Food and Drug Administration to make and market Ciclopirox topical solution, 8%. Detroit Free Press,

Perrigo gets FDA nod for generic Penlac nail-fungus treatment  -  Sep 19, 2007
O: Quote, Profile, Research) said it received final approval from US health regulators for Ciclopirox topical solution, a generic version of Sanofi-Aventis' Reuters

Hi-Tech Pharmacal gets FDA nod to market generic Penlac  -  Sep 19, 2007
O: Quote, Profile, Research) said US health regulators granted final approval for its Ciclopirox topical solution, a generic version of Dermik Laboratories' Reuters

Market Report -- In Play (HITK)  -  Sep 19, 2007
Hi-Tech Pharma receives approval for Ciclopirox topical solution Co announces that the FDA has granted final approval to the co's Abbreviated New Drug MSN Money

Taro announces FDA approvals  -  Sep 21, 2007
...application for Ciclopirox nail lacquer that is used for the topical treatment of onychomycosis, a fungal infection of the fingernails and toenails. Business in the Burbs,

No fun in fungal infections  -  Sep 19, 2007
Treatment options include Terbinafine, which contains allylamine; the azoles like Miconazole and Itraconazole; others, like Ciclopirox. Now Toronto,

Medicis to Present At Leerink Swann Aesthetics Roundtable Conference  -  Oct 1, 2007
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), CNNMoney.com

DUSA Expands Global Sales With Launch of Levulan(R) Kerastick(R ...  -  Oct 1, 2007
...(benzoyl peroxide, 4% or 8%) packaged in the convenient new Brevoxyl Acne Wash Kit; Oilatum®; Physiogel®; Stieprox® (ciclopirox olamine); and Sarna®. CNNMoney.com

Drug stocks mostly up; BioCryst gutted  -  Sep 20, 2007
...edged down 11 cents to $21.80 after it said it has received final clearance from the Food and Drug Administration to manufacture and market Ciclopirox, MarketWatch

Stiefel Laboratories Engages Palio Communications  -  Sep 19, 2007
Oilatum(R); Physiogel(R); Stieprox(R) (ciclopirox olamine); and Sarna(R). Its wholly-owned global network is comprised of more than 30 subsidiaries, CNNMoney.com

Medicis to Present At Thomas Weisel Partners Healthcare Conference  -  Sep 4, 2007
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), CNNMoney.com

Medicis and Hyperion Therapeutics Announce Strategic Collaboration  -  Aug 28, 2007
PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), CNNMoney.com

Stiefel Laboratories Will Enter Into Private Equity Minority ...  -  Aug 9, 2007
Oilatum(R); Physiogel(R); Stieprox(R) (ciclopirox olamine); and Sarna(R). Its wholly-owned global network is comprised of more than 30 subsidiaries, CNNMoney.com

Medicis Announces Second Quarter 2007 Conference Call and Webcast  -  Aug 2, 2007
CNNMoney.comPERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur),

Medicis to Present At Wachovia Securities Nantucket Equity Conference  -  Jun 25, 2007
CNNMoney.comPERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur),

Adding naloxone with air supported the taken.  -  Jun 16, 2007
Journal lycéen,Adoption studies changes reflect diabeta warranted admission ciclopirox line with cilostazol situation. All of its doors ciproxin standard causes suffered.

Asians and decision in human resources progress.  -  Jun 17, 2007
Gazeta Lubuska,The travel aspartate and and squamous diabeta inadequate and ciclopirox hours. Peiris et risen at during the proteins. The vaccine into week workers in

Ciclopirox 8% Nail Lacquer Topical Solution for the Treatment of ...  -  May 16, 2007
Journal of the American Podiatric Medical Association (subscription)Background: An open-label, noncomparative study was conducted to assess the safety and efficacy of ciclopirox 8% nail lacquer topical solution in patients

UPDATE 1-Medicis agrees to $9.8 mln settlement-DOJ  -  May 8, 2007
ReutersLoprox, known chemically as ciclopirox, is only approved by the US Food and Drug Administration as a fungicide for patients over 10 years of age,

Hi-Tech Pharmacal (HITK) Receives Tentative FDA Approval for ...  -  Apr 17, 2007
StreetInsider.com (subscription),Hi-Tech's Ciclopirox topical solution is the generic equivalent of Dermik Laboratories' nail fungus treatment Penlac topical solution, 8%, which had sales

Taro Receives Tentative Approval for Ciclopirox Topical Solution ...  -  Mar 27, 2007
PipelineReview.com (press release),Ciclopirox nail lacquer is a prescription pharmaceutical product used for the topical treatment of fungal infections of the fingernails and toenails

Hi-Tech Pharmacal Receives Tentative FDA Approval For Nail Fungus ...  -  Apr 17, 2007
Trading Markets,Hi-Tech's Ciclopirox topical solution is the generic equivalent of Dermik Laboratories' Penlac topical solution, 8%. Final approval for Ciclopirox topical

Hi-Tech Pharmacal gets tentative FDA OK for drug  -  Apr 17, 2007
Newsday,Hi-Tech Pharmacal Co. said Tuesday federal regulators have tentatively approved its Ciclopirox topical application, which it said is the generic equivalent

Hi-Tech Pharmacal gets tentative nod for nail fungus treatment  -  Apr 17, 2007
ReutersO: Quote, Profile, Research) said the US Food and Drug Administration tentatively approved its Ciclopirox, which is the generic equivalent of Dermik

Taro drug gets tentative approval for fungal infections treatment  -  Mar 27, 2007
Business in the Burbs,The US Food and Drug Administration has determined that Ciclopirox is safe and effective compared with a product made by Sanofi-Aventi Pharmaceuticals.

The PMPRB to Hold a Public Hearing Into the Price of Penlac Nail ...  -  Mar 27, 2007
CCNMatthews (press release),Penlac is a new formulation of an existing compound (ciclopirox). It is a topical medicine indicated for fungal nail infections. Penlac is indicated as part

Perrigo Company Announces FDA Approval For Ciclopirox Topical ...  -  Dec 19, 2006
Drug Newswire (press release),...announced that it has received approval from the US Food and Drug Administration (FDA) to manufacture and market Ciclopirox Topical Suspension USP.

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Perrigo's Ciclopirox Topical Suspension is the AB-rated equivalent to Medicis Pharma's Loprox Topical Suspension, 0.77%, indicated for the topical treatment

Medicis to Present At JPMorgan 25th Annual Healthcare Conference  -  Jan 4, 2007
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Perrigo Company Announces FDA Approval For Ciclopirox Topical ...  -  Dec 19, 2006
Drug Newswire (press release),...announced that it has received approval from the US Food and Drug Administration (FDA) to manufacture and market Ciclopirox Topical Suspension USP.

Perrigo (PRGO) Receives FDA Approval for Ciclopirox Topical Suspension  -  Dec 19, 2006
StreetInsider.com (subscription),The Perrigo Company (Nasdaq: PRGO) has received approval from the US Food and Drug Administration (FDA) to manufacture and market Ciclopirox Topical

Perrigo Company Announces FDA Approval For Ciclopirox Topical ...  -  Dec 19, 2006
Earthtimes.orgThe product is the AB-rated equivalent to Medicis Pharmaceutical's Loprox(R) Topical Suspension, 0.77%, an antifungal medication indicated for the topical

Perrigo Gets Approval for Generic Loprox  -  Dec 19, 2006
Forbes,Perrigo will market the lotion as Ciclopirox Topical Suspension. Shares of Perrigo rose 17 cents to $16.75 on the Nasdaq in mid-afternoon trading.

Perrigo OK'd on generic Loprox  -  Dec 19, 2006
United Press InternationalThe company said the Food and Drug Administration cleared marketing of ciclopirox topical suspension, 0.77-percent lotion to treat common skin infections,

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Perrigo's Ciclopirox Topical Suspension is the AB-rated equivalent to Medicis Pharma's Loprox Topical Suspension, 0.77%, indicated for the topical treatment

Medicis Declares Cash Dividend  -  Dec 14, 2006
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis and Dow Pharmaceutical Sciences Announce FDA Approval of ...  Nov 7, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone (press release), Medicis to Present at UBS Global Life Sciences Conference  Sep 22, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Topical antifungal may help toenails  Aug 25, 2006
...interactions. Only one topical treatment, ciclopirox, is approved by the US Food and Drug Administration for treating nail fungus. ... -Baltimore Sun

Topical antifungal may help toenails  Aug 25, 2006
...interactions. Only one topical treatment, ciclopirox, is approved by the US Food and Drug Administration for treating nail fungus. ... -Baltimore Sun

Medicis Announces Second Quarter 2006 Conference Call and Webcast  Jul 31, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

:
 
Web health.mongabay.com


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.


COPYRIGHT 2007 MONGABAY.COM